Azorim: Does the 2026 Acquisition Wave Build Growth or Delay Deleveraging Again

The main article argued that Azorim has to prove in 2026 that backlog and deliveries finally turn into cash. This follow-up isolates what happened right after the balance sheet date: instead of pausing and letting project surpluses reduce leverage, the company opened three new capital-allocation tracks almost at once, residential land in Rishon LeZion, a retail boulevard acquisition in Ramat Efal, and an examined investment in Yuka Park.

The issue is not that these moves are weak. Quite the opposite. Each one has a clear economic logic. Rishon LeZion adds new future residential inventory, Ramat Efal adds a commercial asset that is meant to sit under the Azorim Prime brand, and Yuka Park could open a new multi-use industrial platform. The problem is sequencing. Before the company has shown that surpluses from existing projects are really easing balance-sheet pressure, it has already opened more uses for capital.

That is also the outside reading. On March 23, 2026, Midroog affirmed the issuer rating at A1.il with a stable outlook, but its base case for leverage improvement explicitly depends on two execution conditions, a completed ILS 200 million equity raise and project-surplus release above ILS 600 million during 2026. Even under those assumptions, Midroog only talks about net debt to net CAP moving from 62% on September 30, 2025 to 60% by the end of 2026, while already building into the scenario roughly ILS 600 million of land and investment-real-estate acquisitions plus additional assumed purchases.

In other words, 2026 is not a clean deleveraging year. It is a capital-allocation proof year. If project surpluses arrive on time, Azorim can expand the asset base and still reduce leverage. If they do not, the company may end up with better assets but the same basic feeling that leverage was only rolled forward.

Three Moves, Three Economic Rationales

This chart deliberately shows only the headline nominal amounts before VAT and before indexation. If anything, that makes the acquisition wave look smaller than it really is. Even so, it highlights the point that is easy to miss on a first read: within less than a month, three separate growth directions were opened, residential development, income-producing retail, and multi-use industrial space.

Rishon LeZion is already the hardest commitment. The company said on February 24, 2026 that its bid was the highest, received the official win notice on March 9, 2026, and completed payment during March. That means the capital use did not remain an intention. It was already executed, even though as of report approval not all suspensive approvals for the purchase agreement had yet been obtained.

Ramat Efal is different. It is not the same immediate cash hit. Fifteen percent of the consideration was paid at signing, 20% is due after 12 months, and 65% is due upon completion, with the whole consideration linked to the construction input index. That makes the timing easier, but not the structure. The company did not just buy an asset, it opened a staged and indexed capital commitment into the next few years.

Yuka Park requires even more discipline. This is not a signed transaction but a strategic examination. Azorim is considering an investment of up to ILS 40 million, partly against a 51% stake and partly as a shareholder loan. It received a 45-day exclusivity period, with a possible 15-day extension. So it would be wrong to write as if the company has already entered a new business line. It is fair to say that management is examining a third capital-allocation direction before the existing ones have proved real cash release.

Not Every Shekel Leaves Tomorrow, and That Is the Point

Any careful reading has to distinguish between timing and commitment. If the lens is only immediate cash flow, it is easy to argue that the worry is exaggerated. Yuka Park is still unsigned, Ramat Efal is spread through the end of 2028, and outside financing remains an option in both Rishon LeZion and Ramat Efal. That is a legitimate point.

But that is not really the question. The real question is whether Azorim chose to prove leverage reduction first and only then open new growth moves, or whether it is trying to do both at the same time. Everything the company itself disclosed points to the second reading. Even when the payment schedule is longer, even when bank or institutional funding is possible, even when part of the move is still non-binding, the bottom line is that management is not sitting still and waiting for surpluses to arrive first.

Another sign comes from the side that could have relieved the pressure. Under the Phoenix framework signed on January 29, 2025, Phoenix is supposed to invest up to ILS 350 million over 72 months in urban-renewal projects, subject to preconditions. By the report date, the parties had already agreed to apply the framework to two projects, but the conditions for actual investments had still not all been completed. So an outside equity cushion exists on paper, but it still has not relieved the tension between expansion and deleveraging.

That is the core of the story. The problem is not that all of these moves carry the same timing or the same weight. The problem is that the overall direction has already turned back toward expansion. In that setup, surplus release from the existing projects is no longer meant only to reduce debt. It also has to fund the next wave.

Midroog Already Wrote the 2026 Test

This chart may be the most important datapoint in the whole follow-up. Net debt to net CAP rose from 58% on September 30, 2024 to 62% on September 30, 2025. Midroog's base case assumes a decline to 60% by the end of 2026. That is still an improvement, but it is only modest, and it comes under a mix of equity raising, strong surplus release, and continued acquisitions.

In other words, the stable rating does not mean Midroog thinks Azorim can expand without a price. It means Midroog believes that under a reasonable base case the company can hold both ends together, spend capital on acquisitions and start reducing leverage at the same time. That scenario is possible. It is simply much more execution-dependent than the headline "stable outlook" tends to imply.

Midroog also says explicitly that the company's acquisition appetite is medium, that after a pause in land purchases during 2023 and 2024 several land and asset transactions were recently reported, and that EBIT to interest coverage is expected to weaken to 1.7 to 1.8 during 2025 through 2027. So even in the external read, Azorim is not entering 2026 with a particularly wide cushion. It is entering with a need to show that the new capital-allocation wave does not cancel out the improvement that existing projects are supposed to generate.

That is where the real question comes from. If surplus release does exceed ILS 600 million, and if the acquisition wave stays within the scale the company has already marked out, 2026 can still be read as a year in which Azorim upgrades the quality of its asset base without lifting leverage again. But if surplus release is delayed, if acquisitions widen, or if outside capital is not closed in time, the whole story can once again look less like a solution and more like a delay.

So Does This Build Growth or Delay Deleveraging

The growth-building side: Rishon LeZion adds future residential inventory, Ramat Efal strengthens the recurring-income leg with an asset meant to be delivered by the end of 2028, and Yuka Park, if signed, can open an activity channel that is not tied only to apartment sales cycles. This is not a random shopping list. There is strategic logic in it.

The deleveraging-delaying side: none of these moves generates immediate surplus that relieves the balance sheet today. In Rishon LeZion the money is already out. In Ramat Efal a new indexed payment schedule has been opened. In Yuka Park a shareholder-loan channel may also open. All of that is happening in a year where even Midroog says leverage improvement depends first on surplus release from projects that already exist.

So the honest answer is that both are true, but not with the same weight and not on the same timeline. The 2026 acquisition wave does build future growth, but for now it mostly delays the point at which anyone can say leverage is falling on its own. Until surpluses from the current project base actually show up on the balance sheet, every new move will be read less by asset quality and more by the question of who is funding it.

The bottom line is simple. Azorim did not choose between growth and deleveraging. It chose to try to execute both together. That can work, but only if over the next 2 to 4 quarters surplus release beats the pace at which new capital uses are being opened. Otherwise the company will end up with a broader portfolio, but the same old argument over whether leverage is truly coming down or just changing address.